Showing In the Press
ADVI’s Marc Samuels and Lindsay Bealor Greenleaf shared insights on the CMS Medicaid final rule policies related to copay coupons and value based arrangements with BioWorld
ADVI’s Marc Samuels and Lindsay Bealor Greenleaf shared insights on the CMS Medicaid final rule policies related to copay coupons and value based arrangements with BioWorld Read the full article here.
Read more
ADVI CEO Marc Samuels examines President-Elect Biden’s priorities for U.S. healthcare in his latest piece for Managed Health Executive
A Biden win, a Republican Senate and a slim Democratic majority in the House: That’s a recipe for compromise. Read the full article here.
Read more
Texas Oncology’s Dr. Debra Patt weighed in with Fierce Healthcare on where the oncology ecosystem stands on the Trump administration’s most-favored-nation final rule
Texas Oncology’s Dr. Debra Patt weighed in with Fierce Healthcare on where the oncology ecosystem stands on the Trump administration’s most-favored-nation final rule Read the full article here.
Read more
ADVI Health estimates year one of the Most Favored Nations (MFN) Model could cut Part B drug payments by $4.2 Billion.
ADVI Health estimates year one of the Most Favored Nations (MFN) Model could cut Part B drug payments by $4.2 Billion.
Read more